301 related articles for article (PubMed ID: 7796869)
1. Pertussis and cholera toxins modulate kappa-opioid receptor agonists-induced hypothermia and gut inhibition.
Shukla VK; Turndorf H; Bansinath M
Eur J Pharmacol; 1995 Mar; 292(3-4):293-9. PubMed ID: 7796869
[TBL] [Abstract][Full Text] [Related]
2. Kappa-opiate agonist-induced inhibition of gastrointestinal transit in different strains of mice.
Bansinath M; Ramabadran K; Turndorf H; Puig MM
Pharmacology; 1991; 42(2):97-102. PubMed ID: 1648236
[TBL] [Abstract][Full Text] [Related]
3. Kappa opioid receptor agonists suppress absence seizures in WAG/Rij rats.
Przewłocka B; Lasoń W; Machelska H; van Luijtelaar G; Coenen A; Przewłocki R
Neurosci Lett; 1995 Feb; 186(2-3):131-4. PubMed ID: 7777181
[TBL] [Abstract][Full Text] [Related]
4. Stereospecific inhibition of gastrointestinal transit by kappa opioid agonists in mice.
Ramabadran K; Bansinath M; Turndorf H; Puig MM
Eur J Pharmacol; 1988 Oct; 155(3):329-31. PubMed ID: 2853069
[TBL] [Abstract][Full Text] [Related]
5. Pretreatment with pertussis toxin differentially modulates morphine- and beta-endorphin-induced antinociception in the mouse.
Tseng LF; Collins KA
J Pharmacol Exp Ther; 1996 Oct; 279(1):39-46. PubMed ID: 8858973
[TBL] [Abstract][Full Text] [Related]
6. The kappa opioid receptor expressed on the mouse R1.1 thymoma cell line down-regulates without desensitizing during chronic opioid exposure.
Joseph DB; Bidlack JM
J Pharmacol Exp Ther; 1995 Mar; 272(3):970-6. PubMed ID: 7891351
[TBL] [Abstract][Full Text] [Related]
7. Differential agonist regulation of the human kappa-opioid receptor.
Blake AD; Bot G; Li S; Freeman JC; Reisine T
J Neurochem; 1997 May; 68(5):1846-52. PubMed ID: 9109509
[TBL] [Abstract][Full Text] [Related]
8. Role of nitric oxide/cyclic GMP in i.c.v. administered beta-endorphin- and (+)-cis-dioxolane-induced antinociception in the mouse.
Xu JY; Tseng LF
Eur J Pharmacol; 1994 Sep; 262(3):223-31. PubMed ID: 7813587
[TBL] [Abstract][Full Text] [Related]
9. Hyperglycaemia as a factor affecting kappa-opiate agonist-induced inhibition of the gastrointestinal transit in mice.
Ramabadran K; Bansinath M; Turndorf H; Puig MM
J Pharm Pharmacol; 1989 Jul; 41(7):496-8. PubMed ID: 2570861
[TBL] [Abstract][Full Text] [Related]
10. The kappa opioid receptor expressed on the mouse R1.1 thymoma cell line is coupled to adenylyl cyclase through a pertussis toxin-sensitive guanine nucleotide-binding regulatory protein.
Lawrence DM; Bidlack JM
J Pharmacol Exp Ther; 1993 Sep; 266(3):1678-83. PubMed ID: 8103800
[TBL] [Abstract][Full Text] [Related]
11. Differential antagonism of bremazocine- and U69,593-induced antinociception by quadazocine: further functional evidence of opioid kappa receptor multiplicity in the mouse.
Horan PJ; de Costa BR; Rice K; Haaseth RC; Hruby VJ; Porreca F
J Pharmacol Exp Ther; 1993 Aug; 266(2):926-33. PubMed ID: 8394923
[TBL] [Abstract][Full Text] [Related]
12. Intracerebroventricular administration of kappa-agonists induces convulsions in mice.
Bansinath M; Ramabadran K; Turndorf H; Shukla VK
Brain Res Bull; 1991 Jul; 27(1):75-9. PubMed ID: 1657321
[TBL] [Abstract][Full Text] [Related]
13. Activation of the cloned human kappa opioid receptor by agonists enhances [35S]GTPgammaS binding to membranes: determination of potencies and efficacies of ligands.
Zhu J; Luo LY; Li JG; Chen C; Liu-Chen LY
J Pharmacol Exp Ther; 1997 Aug; 282(2):676-84. PubMed ID: 9262330
[TBL] [Abstract][Full Text] [Related]
14. Peripheral kappa-opioid receptors mediate the antinociceptive effect of fedotozine (correction of fetodozine) on the duodenal pain reflex inrat.
Diop L; Rivière PJ; Pascaud X; Junien JL
Eur J Pharmacol; 1994 Dec; 271(1):65-71. PubMed ID: 7698213
[TBL] [Abstract][Full Text] [Related]
15. Potentiation of kappa-opioid receptor agonist-induced analgesia and hypothermia by fluoxetine.
Nemmani KV; Gullapalli S; Ramarao P
Pharmacol Biochem Behav; 2001; 69(1-2):189-93. PubMed ID: 11420085
[TBL] [Abstract][Full Text] [Related]
16. Differential antagonism of the rate-decreasing effects of kappa-opioid receptor agonists by naltrexone and norbinaltorphimine.
Powell KR; Holtzman SG
Eur J Pharmacol; 1999 Jul; 377(1):21-8. PubMed ID: 10448921
[TBL] [Abstract][Full Text] [Related]
17. Stimulatory effects of centrally injected kappa-opioid receptor agonists on gastric acid secretion in urethane-anesthetized rats.
Ishihara S; Tsuchiya S; Horie S; Murayama T; Watanabe K
Eur J Pharmacol; 2001 Apr; 418(3):187-94. PubMed ID: 11343688
[TBL] [Abstract][Full Text] [Related]
18. Effects of pertussis toxin on opioid regulation of catecholamine release from rat and guinea pig brain slices.
Werling LL; McMahon PN; Cox BM
Naunyn Schmiedebergs Arch Pharmacol; 1989 May; 339(5):509-13. PubMed ID: 2549429
[TBL] [Abstract][Full Text] [Related]
19. Diminution of contractile response by kappa-opioid receptor agonists in isolated rat ventricular cardiomyocytes is mediated via a pertussis toxin-sensitive G protein.
Wenzlaff H; Stein B; Teschemacher H
Naunyn Schmiedebergs Arch Pharmacol; 1998 Sep; 358(3):360-6. PubMed ID: 9774224
[TBL] [Abstract][Full Text] [Related]
20. Molecular mechanisms of agonist-induced desensitization of the cloned mouse kappa opioid receptor.
Raynor K; Kong H; Hines J; Kong G; Benovic J; Yasuda K; Bell GI; Reisine T
J Pharmacol Exp Ther; 1994 Sep; 270(3):1381-6. PubMed ID: 7932192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
